Involvement of RhoH GTPase in the development of B-cell chronic lymphocytic leukemia

作者：Sanchez Aguilera A; Rattmann I; Drew D Z; Mueller L U W; Summey V; Lucas D M; Byrd J C; Croce C M; Gu Y; Cancelas J A; Johnston P; Moritz T; Williams D A^*

来源：Leukemia, 2010, 24(1): 97-104.

DOI：10.1038/leu.2009.217

• RhoH GTPase
• chronic lymphocytic leukemia
• TCL1 B cells
• lymphopoiesis

RhoH is a hematopoietic-specific, GTPase-deficient member of the Rho GTPase family that functions as a regulator of thymocyte development and T-cell receptor signaling by facilitating localization of zeta-chain-associated protein kinase 70 (ZAP70) to the immunological synapse. Here we investigated the function of RhoH in the B-cell lineage. B-cell receptor (BCR) signaling was intact in Rhoh(-/-) mice. Because RhoH interacts with ZAP70, which is a prognostic factor in B-cell chronic lymphocytic leukemia (CLL), we analyzed the mRNA levels of RhoH in primary human CLL cells and showed a 2.3-fold higher RhoH expression compared with normal B cells. RhoH expression in CLL positively correlated with the protein levels of ZAP70. Deletion of Rhoh in a murine model of CLL (E mu-TCL1(Tg) mice) significantly delayed the accumulation of CD5(+)IgM(+) leukemic cells in peripheral blood and the leukemic burden in the peritoneal cavity, bone marrow and spleen of Rhoh(-/-) mice compared with their Rhoh(+/+) counterparts. Phosphorylation of AKT and ERK in response to BCR stimulation was notably decreased in E mu-TCL1(Tg); Rhoh(-/-) splenocytes. These data suggest that RhoH has a function in the progression of CLL in a murine model and show RhoH expression is altered in human primary CLL samples. Leukemia (2010) 24, 97-104; doi:10.1038/leu.2009.217; published online 22 October 2009

• 出版日期2010-1